{
    "nctId": "NCT02421978",
    "briefTitle": "Inflammation-Induced CNS Glutamate During Breast Cancer Treatment",
    "officialTitle": "Inflammation-Induced CNS Glutamate During Breast Cancer Treatment",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 98,
    "primaryOutcomeMeasure": "Ratio of Glutamate to Creatine",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female breast cancer patients will have undergone surgery (lumpectomy or mastectomy) with or without neoadjuvant or adjuvant chemotherapy\n* Age between 21-65 years\n\nExclusion Criteria:\n\n* Taking trastuzumab",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}